Source: British Journal of Pharmacology. Unidade: FMRP
Assunto: FARMACOLOGIA
ABNT
SOUZA, Danielle G. et al. Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. British Journal of Pharmacology, v. 143, n. 5, p. 541-548, 2004Tradução . . Disponível em: https://doi.org/10.1038/sj.bjp.0705862. Acesso em: 03 out. 2024.APA
Souza, D. G., Bertini, R., Vieira, A. T., Cunha, F. de Q., Poole, S., Allegretti, M., et al. (2004). Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. British Journal of Pharmacology, 143( 5), 541-548. doi:10.1038/sj.bjp.0705862NLM
Souza DG, Bertini R, Vieira AT, Cunha F de Q, Poole S, Allegretti M, Colotta F, Teixeira MM. Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury [Internet]. British Journal of Pharmacology. 2004 ; 143( 5): 541-548.[citado 2024 out. 03 ] Available from: https://doi.org/10.1038/sj.bjp.0705862Vancouver
Souza DG, Bertini R, Vieira AT, Cunha F de Q, Poole S, Allegretti M, Colotta F, Teixeira MM. Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury [Internet]. British Journal of Pharmacology. 2004 ; 143( 5): 541-548.[citado 2024 out. 03 ] Available from: https://doi.org/10.1038/sj.bjp.0705862